Epidiolex maker GW Pharma reports record quarterly revenue of $137 million

United Kingdom-based GW Pharmaceuticals posted higher revenue in the quarter ended Sept. 30, largely driven by U.S. sales of its cannabidiol medicine Epidiolex.

More medical cannabis products available in Peruvian pharmacies

The first finished, registered cannabis medicine became available to patients in Peruvian pharmacies this week, Marijuana Business Daily has learned.

Danish medical cannabis market sees positive quarter

Denmark’s medical cannabis pilot program notched another positive quarter, but the number of unique consumers remains well below the trial’s peak of a year ago.

Australia approves record number of medical cannabis patients

Australia’s medical cannabis market continues to grow. In September, more than 6,000 patients were approved for medical marijuana treatment through the country’s Special Access Scheme (SAS) Category B pathway.

Spain still won’t allow local cannabis market, even as exports are occurring

Spain has several medical cannabis licensed producers, and at least one already exports flower to countries such as Germany.

New CBD product available under prescription in Peru

A new medical cannabis product is available in Peru, another sign the market is moving in the right direction in terms of business opportunities.

German medical cannabis applications for insurance reach 100,000

Applications for medical cannabis reimbursements with German statutory health insurers (GKV) have hit the 100,000 milestone this year – and 62% were approved, according to data obtained by Marijuana Business Daily.

Insurance-covered medical cannabis falls for the first time in Germany

Insurance reimbursements for cannabis in Germany dropped for the first time – on a quarterly basis – since the current medical program started in early 2017, according to new data for the quarter ended June 30, 2020.

Cannabis opportunities growing in these five international markets

These five countries, which span from Europe to Latin America and Oceania, are worth keeping tabs on for their potential business opportunities down the road.

From Israel to Australia, countries with medical marijuana programs are generating revenue

It turns out there are some healthy, and growing, medical marijuana markets outside the United States and Canada – assuming you can look past the cannabis industry fan fiction.

Chile health authority warns of ‘counterfeit’ cannabis medicines

The Public Health Institute of Chile (ISP) issued a warning recently about CBD products offered for sale online without a required sanitary registration.

Danish medicinal cannabis program continues to struggle in early 2020

Denmark reported small growth in the number of patients accessing its medicinal cannabis pilot program early this year, but the overall market remains very small, according to data recently disclosed by the country’s official e-health portal.